Mehrdad Mobasher, Corvus Pharmaceuticals, Inc.'s Chief Medical Officer, appears to have filed an empty initial statement of beneficial ownership. This form is usually filed as a prelude to a company officer either receiving options or buying company shares, so there may be more to come from Mobasher.
Here is the filing.
To get notified when Corvus Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
On September - Sept. 17, 2020
Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020
Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020
Departure of Directors or Certain - Sept. 11, 2020
On September - Sept. 10, 2020